Search - Prime Therapeutics

411 Results for GLP-1 Pipeline Update

Insights from the inaugural BMO Obesity Summit with David Lassen

Lassen, chief clinical officer at Prime Therapeutics/Magellan Rx, shares insights on GLP-1 weight-loss drugs and evidence-based approaches to providing the kind of care we’d want for our loved ones.

PA Sub-Categories: GLP-1 Prime Article: Perspectives
Prime Therapeutics and Magellan Rx to present eight managed care pharmacy research studies at AMCP

Prime/MRx remains at the forefront of GLP-1 research, presenting weight loss studies at this year’s annual meeting.

PA Sub-Categories: GLP-1 Specialty drugs Products Prime Article: Press Releases
AMCP Nexus 2023 live blog: Day 1 collection

Insights from Academy of Managed Care Pharmacy (AMCP) Nexus 2023

PA Sub-Categories: Products Prime Article: Stories
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024

Studies include Prime’s GLP-1 obesity research, the impact of social determinants of health and more.

PA Sub-Categories: GLP-1 Specialty drugs Prime Article: Press Releases